ATE325135T1 - 2-alkylierte cyclodextrinderivate : umkehrungsmittel von medikament-induzierter neuromuskulärer blockierung - Google Patents
2-alkylierte cyclodextrinderivate : umkehrungsmittel von medikament-induzierter neuromuskulärer blockierungInfo
- Publication number
- ATE325135T1 ATE325135T1 AT02712915T AT02712915T ATE325135T1 AT E325135 T1 ATE325135 T1 AT E325135T1 AT 02712915 T AT02712915 T AT 02712915T AT 02712915 T AT02712915 T AT 02712915T AT E325135 T1 ATE325135 T1 AT E325135T1
- Authority
- AT
- Austria
- Prior art keywords
- alkylated
- drug
- neuromuscular block
- reversal agent
- cyclodextrine derivatives
- Prior art date
Links
- 206010029315 Neuromuscular blockade Diseases 0.000 title abstract 2
- 239000012313 reversal agent Substances 0.000 title 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01200535 | 2001-02-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE325135T1 true ATE325135T1 (de) | 2006-06-15 |
Family
ID=8179895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02712915T ATE325135T1 (de) | 2001-02-14 | 2002-02-14 | 2-alkylierte cyclodextrinderivate : umkehrungsmittel von medikament-induzierter neuromuskulärer blockierung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7026304B2 (de) |
| EP (1) | EP1368381B1 (de) |
| JP (1) | JP4313041B2 (de) |
| AT (1) | ATE325135T1 (de) |
| CA (1) | CA2437851C (de) |
| DE (1) | DE60211132T2 (de) |
| ES (1) | ES2261646T3 (de) |
| WO (1) | WO2002064635A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI242015B (en) | 1999-11-29 | 2005-10-21 | Akzo Nobel Nv | 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| AU2004311478A1 (en) | 2003-12-31 | 2005-07-21 | Cydex Pharmaceuticals, Inc. | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
| WO2005088655A1 (en) * | 2004-03-12 | 2005-09-22 | The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | A magnetoresistive medium |
| US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
| US20070178050A1 (en) * | 2005-12-20 | 2007-08-02 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an increased lung depositon |
| US20070160542A1 (en) * | 2005-12-20 | 2007-07-12 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
| US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
| JP2009526858A (ja) * | 2006-02-15 | 2009-07-23 | ティカ レーケメデル アーベー | コルチコステロイド溶液を製造する方法 |
| US12370352B2 (en) | 2007-06-28 | 2025-07-29 | Cydex Pharmaceuticals, Inc. | Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| US8040246B2 (en) * | 2007-12-04 | 2011-10-18 | Avaya Inc. | Systems and methods for facilitating a first response mission at an incident scene |
| CN101591402B (zh) * | 2009-05-05 | 2011-11-30 | 杭州奥默医药技术有限公司 | 6-脱氧砜类环糊精衍生物及其制备方法 |
| DE102010025818A1 (de) | 2010-07-01 | 2012-01-05 | Klaus Jochler | Dosiervorrichtung zur Abgabe von Duft-Desinfektions- oder Reinigungsmittel in Speicherbehälter |
| EP2635273B1 (de) | 2010-11-01 | 2020-01-08 | MEI Pharma, Inc. | Isoflavonoidzusammensetzungen und verfahren zur krebsbehandlung |
| CN116139125A (zh) | 2015-02-02 | 2023-05-23 | 梅制药公司 | 联合治疗 |
| US11097023B1 (en) | 2020-07-02 | 2021-08-24 | Par Pharmaceutical, Inc. | Pre-filled syringe containing sugammadex |
| WO2026085322A1 (en) | 2024-10-18 | 2026-04-23 | Aardvark Therapeutics Inc. | Isoflavonoid formulations and methods of use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4249282B2 (ja) * | 1998-02-27 | 2009-04-02 | 日本食品化工株式会社 | 新規シクロデキストリン誘導体及びその製造方法 |
-
2002
- 2002-02-14 DE DE60211132T patent/DE60211132T2/de not_active Expired - Lifetime
- 2002-02-14 US US10/468,072 patent/US7026304B2/en not_active Expired - Lifetime
- 2002-02-14 WO PCT/EP2002/001667 patent/WO2002064635A1/en not_active Ceased
- 2002-02-14 AT AT02712915T patent/ATE325135T1/de not_active IP Right Cessation
- 2002-02-14 CA CA2437851A patent/CA2437851C/en not_active Expired - Lifetime
- 2002-02-14 JP JP2002564964A patent/JP4313041B2/ja not_active Expired - Lifetime
- 2002-02-14 EP EP02712915A patent/EP1368381B1/de not_active Expired - Lifetime
- 2002-02-14 ES ES02712915T patent/ES2261646T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1368381A1 (de) | 2003-12-10 |
| JP2004526013A (ja) | 2004-08-26 |
| DE60211132T2 (de) | 2006-09-28 |
| DE60211132D1 (de) | 2006-06-08 |
| ES2261646T3 (es) | 2006-11-16 |
| US7026304B2 (en) | 2006-04-11 |
| JP4313041B2 (ja) | 2009-08-12 |
| CA2437851C (en) | 2011-05-17 |
| EP1368381B1 (de) | 2006-05-03 |
| US20040106575A1 (en) | 2004-06-03 |
| WO2002064635A1 (en) | 2002-08-22 |
| CA2437851A1 (en) | 2002-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE325135T1 (de) | 2-alkylierte cyclodextrinderivate : umkehrungsmittel von medikament-induzierter neuromuskulärer blockierung | |
| DK1178958T3 (da) | N-cyanomethylamider som proteaseinhibitorer | |
| DE60236102D1 (en) | 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren | |
| CY1108522T1 (el) | Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της | |
| UY26082A1 (es) | Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica | |
| DE60234409D1 (de) | Säuregenerator, Sulfonsäure, Sulfonsäurederivate und strahlungsempfindliche Zusammensetzung | |
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| DE60112974D1 (en) | Carbolinderivate | |
| ATE355278T1 (de) | Isochinolinon derivate als parp inhibitoren | |
| IS4769A (is) | Píperasín afleiður sem hafa verkjastillandi áhrif, framleiðsla og notkun þeirra | |
| NO20025590D0 (no) | Fenylglycin-derivater | |
| DE60010098D1 (de) | 28-epirapaloge | |
| ATE341537T1 (de) | Dolastatin 10 derivate | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| DE60132618D1 (de) | 4,6-diphenylpyridinderivate als entzündungshemmende mittel | |
| DE60230127D1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| DE60216233D1 (en) | Carbolinderivate | |
| TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
| EA200501557A1 (ru) | Новый способ синтеза (2s)-индолин-2-карбоновой кислоты и использование в синтезе периндоприла | |
| DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
| EA200501925A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
| MXPA03003971A (es) | Derivados de indol como inhibidores de pde5. | |
| CY1108053T1 (el) | Ενωση της κυαμεμαζινης και ενος ατυπου νευροληπτικου | |
| BR0316544A (pt) | Compostos calcilìticos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |